Mingdian Tan

646 total citations · 1 hit paper
13 papers, 401 citations indexed

About

Mingdian Tan is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Mingdian Tan has authored 13 papers receiving a total of 401 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 3 papers in Pulmonary and Respiratory Medicine and 3 papers in Cancer Research. Recurrent topics in Mingdian Tan's work include Extracellular vesicles in disease (3 papers), MicroRNA in disease regulation (3 papers) and Hepatocellular Carcinoma Treatment and Prognosis (2 papers). Mingdian Tan is often cited by papers focused on Extracellular vesicles in disease (3 papers), MicroRNA in disease regulation (3 papers) and Hepatocellular Carcinoma Treatment and Prognosis (2 papers). Mingdian Tan collaborates with scholars based in United States, China and Denmark. Mingdian Tan's co-authors include Hou-Hsien Chiang, Rika Ohkubo, Hanzhi Luo, Qi Qiao, Hao Wu, Wei‐Chieh Mu, Ming He, Li Wang, Shimin Zhao and Danica Chen and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cell Metabolism and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Mingdian Tan

12 papers receiving 396 citations

Hit Papers

An Acetylation Switch of the NLRP3 Inflammasome Regulates... 2020 2026 2022 2024 2020 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mingdian Tan United States 8 238 84 79 60 60 13 401
Boquan Wu China 13 357 1.5× 64 0.8× 79 1.0× 54 0.9× 50 0.8× 23 548
Yun-Hee Bae South Korea 11 179 0.8× 48 0.6× 87 1.1× 38 0.6× 45 0.8× 14 384
Dechao Zhao China 11 180 0.8× 35 0.4× 53 0.7× 22 0.4× 77 1.3× 18 368
Yajing Lu China 12 178 0.7× 76 0.9× 77 1.0× 25 0.4× 24 0.4× 21 406
Sandra S. Hammer United States 11 246 1.0× 67 0.8× 31 0.4× 29 0.5× 58 1.0× 18 474
Yinghao Jiang China 10 192 0.8× 47 0.6× 91 1.2× 27 0.5× 165 2.8× 20 410
Radu C. Oita United States 11 122 0.5× 63 0.8× 129 1.6× 40 0.7× 75 1.3× 15 414
Francesca Cuomo Italy 7 193 0.8× 27 0.3× 139 1.8× 191 3.2× 93 1.6× 8 445

Countries citing papers authored by Mingdian Tan

Since Specialization
Citations

This map shows the geographic impact of Mingdian Tan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingdian Tan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingdian Tan more than expected).

Fields of papers citing papers by Mingdian Tan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mingdian Tan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingdian Tan. The network helps show where Mingdian Tan may publish in the future.

Co-authorship network of co-authors of Mingdian Tan

This figure shows the co-authorship network connecting the top 25 collaborators of Mingdian Tan. A scholar is included among the top collaborators of Mingdian Tan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mingdian Tan. Mingdian Tan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Tan, Mingdian, Ye Wei, Yi Liu, et al.. (2025). Niclosamide prodrug enhances oral bioavailability and efficacy against hepatocellular carcinoma by targeting vasorin‐TGFβ signalling. British Journal of Pharmacology. 182(22). 5517–5535. 1 indexed citations
2.
Lin, Baihan, et al.. (2025). Design and additive manufacture of patient-specific head phantom for radiotherapy. Materials & Design. 252. 113719–113719.
3.
Liu, Yi, David Lechuga‐Ballesteros, Mingdian Tan, et al.. (2024). Lipid-Based Self-Microemulsion of Niclosamide Achieved Enhanced Oral Delivery and Anti-Tumor Efficacy in Orthotopic Patient-Derived Xenograft of Hepatocellular Carcinoma in Mice. International Journal of Nanomedicine. Volume 19. 2639–2653. 7 indexed citations
4.
Ji, Jinjun, Lingbo Wang, Mingzhe Xiao, et al.. (2024). LIF Promotes Sec15b‐Mediated STAT3 Exosome Secretion to Maintain Stem Cell Pluripotency in Mouse Embryonic Development. Advanced Science. 11(48). e2407971–e2407971. 1 indexed citations
5.
Tan, Mingdian, Xiaogang Wang, Yan Wang, et al.. (2023). Extracellular Vesicles (EVs) in Tumor Diagnosis and Therapy. Technology in Cancer Research & Treatment. 22. 2223913351–2223913351. 9 indexed citations
6.
Tan, Mingdian, et al.. (2023). Rational design, synthesis and structural characterization of peptides and peptidomimetics to target Hsp90/Cdc37 interaction for treating hepatocellular carcinoma. Computational and Structural Biotechnology Journal. 21. 3159–3172. 7 indexed citations
7.
Natarajan, Arutselvan, Hui Zhang, Ye Wei, et al.. (2021). A Humanized Anti-GPC3 Antibody for Immuno-Positron Emission Tomography Imaging of Orthotopic Mouse Model of Patient-Derived Hepatocellular Carcinoma Xenografts. Cancers. 13(16). 3977–3977. 19 indexed citations
8.
Shi, Hui, Mingdian Tan, Hongguang Liu, et al.. (2021). NIR-II imaging of hepatocellular carcinoma based on a humanized anti-GPC3 antibody. RSC Medicinal Chemistry. 13(1). 90–97. 14 indexed citations
9.
Wang, Xiaogang, Qianqian Shi, Li Cui, et al.. (2020). Tumor-derived exosomes facilitate tumor cells escape from drug therapy in clear cell renal cell carcinoma. Translational Cancer Research. 9(5). 3416–3425. 9 indexed citations
10.
He, Ming, Hou-Hsien Chiang, Hanzhi Luo, et al.. (2020). An Acetylation Switch of the NLRP3 Inflammasome Regulates Aging-Associated Chronic Inflammation and Insulin Resistance. Cell Metabolism. 31(3). 580–591.e5. 310 indexed citations breakdown →
11.
Hafeez, S., K. Warren-Oseni, David P. Dearnaley, et al.. (2020). Dose Escalated Adaptive Bladder Radiotherapy: Clinical Outcomes of a Phase I Study. International Journal of Radiation Oncology*Biology*Physics. 108(3). S29–S29. 1 indexed citations
12.
Yin, Li, Mingdian Tan, Weixing Dai, et al.. (2020). Impact of postoperative radiotherapy for T3N0M0 esophageal cancer patients: A population‐based study. SHILAP Revista de lepidopterología. 10(3). e143–e143. 3 indexed citations
13.
Qiao, Yunbo, Lingbo Wang, Jun Chen, et al.. (2017). Opposing Roles of Acetylation and Phosphorylation in LIFR-Dependent Self-Renewal Growth Signaling in Mouse Embryonic Stem Cells. Cell Reports. 18(4). 933–946. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026